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Abstract
Nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain contain-
ing 3 (NLRP3) has recently emerged as a central regulator of innate immunity and inflam-
mation in response to both sterile inflammatory and microbial invasion signals. Although its
ability to drive proteolytic procaspase-1 processing has drawn more attention, NLPR3 can
also activate NF-κB. To clarify the physiological relevance of this latter function, we exam-
ined the effect of NLRP3 on NF-κB activation and cytokine induction in RNA-interference-
based NLRP3-knockdown cell lines generated from the human monocytic cell line THP-1.
Knocking down NLRP3 reduced NF-κB activation and cytokine induction in the early stages
of Staphylococcus aureus infection. Expression of cytokine genes induced by Staphylococ-
cus aureus was not inhibited by a caspase-1 inhibitor, and did not occur through an auto-
crine mechanism in response to newly synthesized cytokines. We also demonstrated that
NLRP3 could activate NF-κB and induce cytokines in response to sterile signals, monoso-
dium urate crystals and aluminum adjuvant. Thus, NLRP3 mediates NF-κB activation in
both sterile and microbially induced inflammation. Our findings show that not only does
NLRP3 activate caspase-1 post-translationally, but it also induces multiple cytokine genes
in the innate immune system.
Introduction
Nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain contain-
ing 3 (NLRP3, also called cryopyrin, NALP3, and PYPAF1, induces inflammatory responses
and cell death in response to various danger signals. These signals include pathogen-associated
molecular patterns (PAMPs), such as bacterial and viral RNA and muramyl dipeptide [1–7];
damage-associated molecular patterns (DAMPs), such as ATP, uric acid crystals, cholesterol
crystals, and amyloid-β [8–15]; and environmental inflammatory substrates such as asbestos
and silica [16, 17]. Thus, NLRP3 is implicated not only in infectious diseases, but also in sterile
inflammation in conditions such as gout, atherosclerosis, Alzheimer’s disease, asbestosis, and
silicosis. Gain-of-function NLRP3 mutations cause a subset of autoinflammatory diseases
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collectively called cryopyrin-associated periodic syndrome (CAPS) [18, 19]. When activated,
NLRP3 joins with caspase-1 and the adaptor molecule apoptosis-associated speck-like protein
containing a caspase recruitment domain (ASC) to form a multi-protein complex called the
inflammasome, which controls caspase-1 activation. Activated caspase-1, in turn, cleaves pro-
IL-1β and pro-IL-18 into their biologically active secretory forms [20–22].
For macrophages to produce mature IL-1β, two signals are required. The first (signal 1) acti-
vates NF-κB and induces pro-IL-1β synthesis, and the second (signal 2) activates caspase-1 and
induces the proteolytic maturation of pro-IL-1β. Since NF-κB activation in response to PAMP
stimulation and bacterial infection is normal in macrophages from NLRP3−/− or ASC−/−mice
[12, 13], NLRP3 has been considered dispensable for signal 1 in mice. While the TLR pathway
is generally believed to mediate signal 1 in the case of pathogen-stimulated macrophages, it is
not clear how this signal is mediated in sterile inflammation.
Genetic reconstitution experiments using HEK293 cells have shown that human NLRP3
can activate NF-κB [23, 24] in cooperation with ASC. ASC-deficient human monocytic THP-1
cells show defective NF-κB activation and cytokine production in response to Porphyromonas
gingivalis infection [25]. However, the role of human NLRP3 in activating NF-κB, especially
under sterile inflammatory conditions, has not been examined.
To address human NLRP3's role in the NF-κB signaling pathway, we generated THP-1-de-
rived NLRP3-knockdown cells and demonstrated that NLRP3 mediates NF-κB activation and
cytokine gene induction in a caspase-1 independent manner. More importantly, NLRP3 could
activate NF-κB and induce cytokines following stimulation by monosodium urate (MSU) crys-
tals and aluminum adjuvant, sterile activators for NLRP3. These results suggest that NLRP3 is
important for NF-κB activation, especially in sterile inflammatory diseases.
Methods
Reagents
Doxycycline (Dox) was purchased from AppliChem (Darmstadt, Germany), recombinant
human IL-1Ra from Genzyme (Cambridge, MA, USA), recombinant human IL-1β from
PeproTech (London, UK), Ac-YVAD-CMK from Bachem (Torrance, CA, USA), bafilomycin
A1 from Fermenteck (Jerusalem, Israel), and CA-074Me fromMerck (Darmstadt, Germany).
Diphenyleneiodonium (DPI) was purchased from Enzo (Plymouth Meeting, PA, USA). LPS
from Escherichia coli K235 was purchased from Sigma-Aldrich (St. Lois, MO, USA). ATP was
purchased from YAMASA CORPORATION (Chiba, Japan). Cycloheximide (CHX) and MSU
crystals were purchased fromWako Pure Chemical Industries (Osaka, Japan). Aluminum ad-
juvant (Imject Alum) was purchased from Pierce (Rockford, IL, USA). Ficoll-Paque PLUS was
purchased from GE Healthcare Japan (Tokyo, Japan).
Generation of micro RNA-based knockdown cell lines under the control
of a Tet-on system
Expression cassettes for artificial micro RNAs (miRNAs) targeting NLRP3, ASC, and MyD88
and for negative control miRNAs were generated using the BLOCK-iT Pol II miR RNAi Expres-
sion Vector Kit (Life Technologies, Carlsbad, CA, USA) and the following target sequences: for
NLRP3, 50-TCCTGAATCAGACTGAAGGCT-30; for ASC, 50-TAGGTCTCCAGGTAGAAG
CTG-30; and for MyD88, 50-TCTCCAAGTACTCAAAGTCCA-30. The DNA fragment containing
the microRNA expression cassette was cloned into a Tet-on lentiviral vector pLVCT-tTRKRAB
(Addgene, Cambridge, MA, USA) and transferred into HEK293FT packaging cells using the
packaging vectors pMD2G and psPAX2. Recombinant lentiviruses collected from the culture
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supernatant were used to transduce THP-1 cells. We used vector-coded GFP to select THP-1 cells
that expressed pLVCT-tTRKRAB-derived miRNA. The collected cells were cultured without Dox
or treated with Dox for 5 d to induce miRNA expression.
Generation of short hairpin (sh) RNA-based knockdown cell lines
The target sequence for NLRP3 (50-GCTGGAATTGTTCTACTGTTT-30) and a negative con-
trol sequence (50-CCTAAGGTTAAGTCGCCCTCG-30) were used to generate oligonucleotide
pairs that were inserted into the pLKO.1 TRC cloning vector (Addgene) to produce lentiviral
vectors that were used to transduce THP-1 cells. THP-1 cells stably expressing shRNA were se-
lected by puromycin resistance for 2 weeks, and these cells were used for experiments.
Cell culture and infection with Staphylococcus aureus (S. aureus)
The THP-1 cell line (ATCC TIB-202) and its derivatives expressing miRNA or shRNA were
cultured in RPMI 1640 medium supplemented with 10% FCS. To induce IL-1β release, 1x105
cells were primed with LPS (20 ng/ml) for 12 h and then with ATP (3 mM) for 1 h. Unprimed
THP-1 and THP-derived cells were used for bacterial-infection and MSU-stimulation experi-
ments. For bacterial-infection experiments, S. aureus (strain Smith, kindly provided by Dr,
Nakanishi, Kanazawa University, Ishikawa, Japan) was grown in Luria broth until OD 1.9–2.2
at 600 nm, then collected and washed in RPMI 1640 with 10% FCS.
Isolation of primary human monocytes
50 ml of fresh blood from a healthy donor was fractionated using 1.074 g/ml density barrier so-
lution as described [26]. A monocyte-enriched fraction (purity> 80%) was prepared using
Pan Monocyte Isolation Kit (Milteny Biotec K.K., Tokyo, Japan).
Transfection of siRNAs
The NLRP3-targeted (HSS132811), MyD88-targeted (#428431 and #42832), ASC-targeted
(HSS147064), and control siRNA (12395-115 and 12395-113) were purchased from Life Tech-
nologies. THP-1 and primary human monocyte were transfected with siRNA (20 nM) using
the Neon Transfection System (Life Technologies).
Western blot analysis
Immunoblotting was performed as described previously [27]. A hybridoma producing mAb
against human NLRP3 was established using lymph node cells from mice immunized with re-
combinant NLRP3 (amino-acids 1–266). An anti-human ASC mouse mAb was prepared as de-
scribed previously (27). Anti-p38 rabbit polyclonal Ab, anti-p54/p46 (JNK) rabbit mAb
(56G8), anti-p44/p42 (ERK) rabbit mAb (137F5), anti-phospho-p-38 rabbit polyclonal Ab,
anti-phospho-p54/p46 (JNK) rabbit mAb (81E11), and anti-phospho-p44/p42 (ERK) rabbit
mAb (D13.14.4E) were purchased from Cell Signaling Technology (Beverly, MA). Anti-human
IL-1βmouse mAb (8516) were purchased from R&D Systems (Minneapolis, MN). Anti-β-
actin mouse mAb (AC-15) was purchased from Sigma-Aldrich.
ELISA
The amount of human TNF-α, IL-1β, and IL-8 in culture supernatants was determined using
the OptEIA ELISA kit (BD Pharmingen, Tokyo, Japan) according to the manufacturer’s
protocol.
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EMSA
EMSA was performed as described previously [28].
RT-PCR
Real-time PCR was performed with primers for TNF-α (forward 50-ATGAGCACTGAAAG
CATGATCC-30, reverse 50-GAGGGCTGATTAGAGAGAGGTC-30), IL-1β (forward 50-CTCG
CCAGTGAAATGATGGCT-30, reverse 50-GTCGGAGATTCGTAGCTGGAT-30), and MyD88
(forward 50-CCCCAGCGACATCCAGTTT-30, reverse 50-GGCACCTCTTTTCGATGAGC-30).
Semiquantitative RT-PCR was performed as described previously [23] with primers for TNF-α
(forward 50-AAGGACACCATGAGCACTGA-30, reverse 50-CGTTTGGGAAGGTTGGATG
TT-30), IL-1β (forward 50-AGCTGAGGAAGATGCTGGTT-30, reverse 50-CCAGGAAGAC
GGGCATGTTT-30), and MyD88 (forward 50-GACCCCCTGGGGCAT-30, reverse 50-TC
AGGGCAGGGACAA-30).
Statistical analysis
All experiments were done in duplicate or triplicate and repeated at least three times. Error
bars indicate standard deviations. Statistical significance of difference between two experimen-
tal groups was accessed by two-tailed Student’s t-test. P-values are indicated in the text and fig-
ures above the two groups. P<0.05 was considered statistically significant.
Results
NF-κB activation and cytokine induction by S. aureus infection were
reduced in NLRP3- and ASC-knockdown cell lines
To determine NLRP3's role in activating NF-κB in human monocytes, we generated Dox-in-
ducible, artificial miRNA-based NLRP3- or ASC-knockdown cell lines (miNLRP3 and miASC,
respectively) by transducing human monocytic THP-1 cells with Tet-on-regulated lentiviral
vectors expressing miRNA against NLRP3 or ASC. Before Dox treatment, the NLRP3 and ASC
protein levels in miNLRP3 and miASC cells, respectively, were the same or slightly lower than
those in cell lines transduced with negative-control miRNA (miCtrl) (Fig. 1A). After Dox treat-
ment, the NLRP3 and ASC protein levels were markedly reduced in miNLRP3 cells and
miASC cells, respectively, but were unaffected in miCtrl cells. In accordance with these results,
the IL-1β secretion induced by LPS plus ATP was also reduced in the Dox-treated miNLRP3
and miASC cells (Fig. 1B), further confirming the effectiveness of the target-protein knock-
down by this system.
We used the same cell lines to examine NLRP3's role in activating NF-κB and inducing cy-
tokines in response to S. aureus infection [13]. In the Dox-treated NLRP3- and ASC-knock-
down cells, not only IL-1β but also TNF-α and IL-8 secretion was dampened through 120 min
after S. aureus infection (Fig. 1C and Fig. A in S1 File), although TNF-α and IL-8 levels in
miNLRP3 and miASC cell culture supernatants were comparable in Dox-treated and -untreat-
ed cells at a later time point, 180 min after S. aureus infection (Fig. B in S1 File). The TNF-α
and IL-1βmRNA induction in response to S. aureus infection was comparable among all cell
lines before Dox treatment (Fig. 1D). In contrast, the induction of TNF-α and IL-1βmRNA
was markedly reduced in Dox-treated miNLRP3 and miASC cells, but not in miCtrl cells. The
effect of NLRP3 knockdown on cytokine induction in early stages of S. aureus infection was re-
produced by experiments using shRNA-based NLRP3-knockdown cells (Fig. C in S1 File).
EMSA evaluation of the NF-κB activation after S. aureus infection showed comparable
shifted bands corresponding to the NF-κB-DNA complex in the nuclear extracts from all cell
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lines that were not treated with Dox (Fig. 1E, left panel, lane 2, 4, and 6), indicating similar
NF-κB activation in these cell lines. In contrast, Dox treatment (Fig. 1E, right panel, lane 10
and lane 12) diminished the NF-κB activation in cells expressing miNLRP3 or miASC. In
Fig 1. NF-κB activation and cytokine induction in S. aureus–infected THP-1 cells are reduced by NLRP3-knockdown. (A) THP-1 cells containing
negative control miRNA (miCtrl), NLRP3miRNA (miNLRP3), or ASCmiRNA (miASC) were cultured with or without 2 ng/ml Dox for 5 d. Cells were collected
and analyzed byWestern blot with anti-NLRP3, anti-ASC, and anti-β-actin Abs. Numbers below lanes indicate band intensities relative to Dox-untreated
control cells. (B) The indicated cell lines were stimulated with LPS (20 ng/ml) for 12 h and then pulsed with ATP (3 mM) for 1 h. IL-1β release was analyzed by
ELISA. (C) ELISA analysis of TNF-α and IL-1β release in Dox-treated or –untreated cell lines infected with S. aureus at a multiplicity of infection (MOI) of 4 for
the time periods indicated. Data are mean ± s.d. of triplicate samples. (D) Real-time PCR analysis of TNF-α and IL-1βmRNA in Dox-treated or -untreated cell
lines infected with S. aureus at an MOI of 2 for 80 min. Values are relative to an average in uninfected, Dox-untreated miCtrl cells (set as 1). Values represent
the averages of duplicate wells, and error bars represent the range. (E) Cells treated with or without Dox were infected with S. aureus at an MOI of 2 for 1 h,
and NF-κB activation was examined by EMSA. The positions of nonspecific bands (ns) and shifted bands (arrowhead) are indicated. (F) Western blot
analysis of p-p38, p-p54/p46 (JNK), and p-p44/p42 (ERK) in Dox-treated or -untreated cell lines infected with S. aureus at an MOI of 2 for 1 h. All results are
representative of three independent experiments. *P<0.05, **P<0.01.
doi:10.1371/journal.pone.0119179.g001
NLRP3 Mediates NF-κB Activation
PLOS ONE | DOI:10.1371/journal.pone.0119179 March 11, 2015 5 / 15
miCtrl cells, NF-κB was activated at comparable levels before and after Dox treatment (lanes 2
and 8).
MAPK pathways also contribute to cytokine production in response to bacterial infection.
In fact, MAPKs (p38, JNK, and ERK) were activated early in S. aureus infection in the context
used in this study (Fig. 1F). However, NLRP3 and ASC knockdown did not affect p38, JNK, or
ERK phosphorylation, suggesting that the MAPK pathway is independent of the NLRP3-
ASC pathway.
Together, these results indicate that NLRP3 plays an important role in activating NF-κB
and inducing cytokine genes in THP-1 cells in response to microbial infection.
TLRs redundantly activate NF-κB at an early stage of S. aureus infection
When TLRs recognize bacterial ligands, they activate NF-κB to provoke the release of proin-
flammatory cytokines. To examine whether the TLR pathway is also involved in activating NF-
κB and releasing cytokines in the early stages of infection, we generated MyD88-knockdown
cell lines based on a Tet-on system. MyD88 mRNA was slightly reduced in the MyD88
miRNA-introduced (miMyD88) cells even before Dox treatment, and was reduced further by
Dox treatment (Fig. 2A and Fig. 2B). Following S. aureus infection in the Dox-treated MyD88-
knockdown cells, TNF-α release evaluated by ELISA (Fig. 2C) and NF-κB activation evaluated
by EMSA (data not shown) were lower than in Dox-untreated cells. Thus, the NLPR3 and TLR
signaling pathways seem to mediate NF-κB activation redundantly or cooperatively in the
early stages of S. aureus infection.
NLRP3 mediates NF-κB activation in sterile inflammation
To further investigate the pathophysiological significance of the NLRP3-mediated NF-κB acti-
vation, we examined the effect of NLRP3 knockdown on uric acid-induced inflammatory re-
sponses. MSU-induced TNF-α and IL-1βmRNA was reduced in the NLRP3-knockdown
(shNLRP3) cells compared to control (shCtrl) cells (Fig. 3A). Consistent with this result, MSU-
induced TNF-α and IL-1β secretion and intracellular pro-IL-1β accumulation were markedly
reduced in shNLRP3 cells (Fig. 3B and Fig. 3C). The involvement of NLRP3 and ASC in MSU-
induced TNF-α and IL-1β expression was confirmed using NLRP3 and ASC-targeting siRNAs,
respectively (Fig. D in S1 File). Knocking down MyD88 by miRNA and siRNA reduced the IL-
1β- and LPS-induced but not the MSU-induced TNF-αmRNA, indicating that the TLR path-
way is not involved in the MSU-induced NF-κB activation (Fig. 3D and Fig. 3E). These results
also rule out the possibility that contaminated LPS was responsible for the MSU-induced cyto-
kine gene expression.
To further confirm the role of NLRP3 in sterile inflammation, we next examined the effect
of NLRP3 knockdown on aluminum adjuvant-induced inflammatory responses. For this pur-
pose, PMA-primed shCtrl and shNLRP3 cells were stimulated with aluminum adjuvant. In
shNLRP3 cells, the extent of aluminum adjuvant-induced IL-1βmRNA induction was signifi-
cantly lower than those in shCtrl cells (Fig. 3F). Similar results were obtained in the experi-
ments using unprimed primary human monocytes (Fig. 3G). Together, these results indicate
that NLRP3 plays an essential role in the NF-κB activation in sterile inflammation.
No autocrine mechanism is involved in inducing cytokines in early
stages of infection
The NLRP3-dependent NF-κB activation and cytokine mRNA induction noted above could
have been mediated by quickly released IL-1β through an autocrine mechanism. However, this
is unlikely because MyD88 knockdown inhibited the IL-1β-induced but not the MSU-induced
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TNF-α expression, as described above. To further examine whether the cytokines induced in
early infection were mediated by quickly released IL-1β, THP-1 cells were pre-incubated with
recombinant IL-1ra, which effectively suppresses the amount of IL-8 released in response to 10
ng/ml recombinant IL-1β, a dose 80–100 times higher than that induced by S. aureus infection
(Fig. 4A). IL-1Ra-treated and -untreated cells secreted IL-8 and TNF-α at comparable levels in
response to S. aureus infection (Fig. 4B). Consistent with these findings, the caspase-1 inhibitor
Ac-YVAD-CMK, which completely blocks IL-1β and IL-18 secretion in response to S. aureus
infection (Fig. 4C, right panel and Fig. 4G, left panel), did not affect TNF-α secretion (Fig. 4C,
left panel). Furthermore, while CHX pre-incubation markedly reduced the TNF-α and IL-1β
secretion in response to S. aureus infection (Fig. 4D), it did not inhibit TNF-α and IL-1β
mRNA induction (Fig. 4E). These results indicate that the mRNA induction seen in early S.
Fig 2. TLRs are involved in activating NF-κB in early S. aureus infection. (A and B) Control cells (miCtrl)
and MyD88miRNA-introduced cells (miMyD88) were cultured with or without 2 ng/ml Dox for 5 d. The total
RNA was analyzed for MyD88 mRNA by RT-PCR (A) and real-time PCR (B); numbers below lanes indicate
each band's intensity relative to a Dox-untreated control. (C) ELISA analysis of TNF-α released from each
Dox-treated or -untreated cell line infected with S. aureus at an MOI of 4 for 120 min. Values represent the
averages of duplicate wells, and error bars represent the range. All results are representative of three
independent experiments. *P<0.05, **P<0.01.
doi:10.1371/journal.pone.0119179.g002
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Fig 3. NLRP3mediates NF-κB activation in sterile inflammation. (A and B) Real-time PCR analysis (A) and ELISA analysis (B) of TNF-α and IL-1β in
shCtrl and shNLRP3 cell lines treated with 150 μg/ml MSU crystals for 90 min (A) or indicated period (B). (C) Immunoblot analysis of pro-IL-1β in cell lines
treated with MSU crystals for the times indicated. (D) Real-time PCR analysis of TNF-αmRNA in cells treated with recombinant human IL-1β (1 ng/ml) or
MSU crystals for 90 min. Values are normalized to an average of 1 in untreated cells. (E) Real-time PCR analysis of MyD88 (left panel) and TNF-αmRNA
NLRP3 Mediates NF-κB Activation
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aureus infection is not mediated by an autocrine mechanism involving newly synthesized cyto-
kines. In addition, the MSU-induced TNF-α secretion from THP-1 cells (Fig. 4F, left panel)
and aluminum adjuvant-induced TNF-α and IL-1βmRNA expression from human peripheral
blood monocytes (Fig. E in S1 File) were not affected by Ac-YVAD-CMK, which dampens
MSU-induced IL-1β and IL-18 secretion (Fig. 4F, right panel and Fig. 4G, right panel). These
results exclude the possible involvement of caspase-1-dependent secretion of cytokines includ-
ing IL-1β and IL-18 in the induction of TNF-α.
NLRP3 mediates NF-κB activation downstream of lysosomes
To explore the signaling pathway by which NLRP3 activates NF-κB, we examined a proposed
phagolysosome destabilization model for procaspase-1 activation [29, 30]. Pre-incubating con-
trol and knockdown cells with bafilomycin A1, which neutralizes the lysosomal pH and pre-
vents lysosomal protease maturation, completely blocked the TNF-αmRNA induction and
cytokine release (Fig. 5A and Fig. 5B) in the early stages of S. aureus infection. The cytokine re-
lease was markedly reduced by pre-incubating control and knockdown cells with the cathepsin
B inhibitor CA-074Me (Fig. 5C, CA-074Me). Similarly, the MSU-induced TNF-α secretion
was markedly reduced by pre-incubating cells with cytochalasin D, bafilomycin A1, or the
NADPH oxidase inhibitor DPI (Fig. 5D and 5E). These results indicate that NLRP3 mediates
NF-κB activation downstream of phagolysosome pathways and suggest that, in both sterile and
microbially induced immune responses, NF-κB and inflammasomes may be
activated concurrently.
Discussion
In this study, we generated RNA-interference-based knockdown cells from the human mono-
cytic THP-1 cell line, and demonstrated that NLRP3 is required for optimal NF-κB activation
following S. aureus infection. Previous studies using macrophages from NLRP3−/−mice dem-
onstrated that NLRP3 is dispensable for NF-κB activation following S. aureus infection [13];
this difference may be species-specific or may result from experimental conditions. In previous
studies, mouse macrophages were primed with LPS, which strongly induces TLR4-mediated
NF-κB activation, prior to bacterial infection; this would mask NLRP3-mediated NF-κB activa-
tion. In our experimental system, NLRP3-NF-κB activation could be detected only during
early stages of infection (Fig. 1 and Fig. B in S1 File), probably because NF-κB is primarily acti-
vated through the TLR pathway at later stages of infection.
In sterile inflammatory diseases, signal 1 (for NF-κB activation leading to pro-IL-1βmRNA
induction) has been unclear. It has been proposed that TLRs might mediate signal 1 by sensing
DAMPs such as high mobility group box-1, hyaluronic acid, and biglycan, which are released
from dead cells or extracellular matrix upon tissue injury [2, 31–35]. The data presented here
show that NLRP3 is also able to mediate signal 1. Thus, NLRP3 mediates not only signal 2 but
also signal 1 to produce IL-1β in sterile inflammation. In primary human monocytes, NLRP3
was also shown to mediate IL-1βmRNA induction. This could explain the spontaneous release
of IL-1β by monocytes isolated from CAPS patients carrying gain-of-function NLRP3
(middle and right panel) in negative-control siRNA-introduced (siCtrl) and MyD88 siRNA-introduced (siMyD#1, #2) cells left untreated (left panel) or treated
with 10 ng/ml LPS (middle panel) or 150 μg/ml MSU crystals (right panel) for 60 min. (F) Real-time PCR analysis of IL-1βmRNA in shCtrl and shNLRP3 cell
lines treated with 250 μg/ml aluminum adjuvants (Alm) for 140 min. (G) Real-time PCR analysis of NLRP3 (left panel) and IL-1βmRNA (right panel) in
negative-control siRNA-introduced (siCtrl) and NLRP3 siRNA-introduced (siNLRP3) primary humanmonocytes treated with (right panel Alm +) or without
(left panel, and right panel Alm −) 250 μg/ml of aluminum adjuvant for 140 min. All results are representative of at least three independent experiments.
*P<0.05, **P<0.01.
doi:10.1371/journal.pone.0119179.g003
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Fig 4. Cytokine induction in early infection does not involve an autocrine mechanism. (A) After incubation with the indicated amount of recombinant
human IL-1Ra for 30 min, miCtrl cells were stimulated with recombinant human IL-1β for 60 min, and the IL-8 secretion was analyzed by ELISA. (B) After
incubation with 100 ng/ml IL-1Ra for 30 min, miCtrl cells were infected with S. aureus at an MOI of 4 for the times indicated. IL-8 and TNF-α secretion from
each cell line were analyzed by ELISA. (C) After incubation with 20 μMAc-YVAD-CMK for 30 min, Dox-untreated miCtrl and miNLRP3 cells were infected
with S. aureus for 100 min. TNF-α and IL-1β secretion were analyzed by ELISA. (D) THP-1 cells were incubated with 5 μg/ml CHX for 30 min and then
infected with S. aureus at an MOI of 4 for the indicated times. TNF-α and IL-1β secretion were analyzed by ELISA. (E) THP-1 cells were treated with CHX and
infected as in (D). The total RNA was analyzed for TNF-α and IL-1βmRNA by RT-PCR. (F) ELISA analysis of TNF-α and IL-1β released from THP-1 cells
treated with MSU in the presence or absence of 0.63, 1.25, 2.5, 5, and 10 μMAc-YVAD-CMK for 180 min. (G) ELISA analysis of IL-18 released from THP-1
cells treated as in (C) (left panel) or treated with MSU in the presence or absence of 10 μM of Ac-YVAD-CMK for 20 h (right panel). All results are
representative of three independent experiments. ND, not detected.
doi:10.1371/journal.pone.0119179.g004
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Fig 5. NLRP3mediates NF-κB activation downstream of lysosomes. (A) After being cultured with or without Dox for 5 d, miCtrl and miNLRP3 cells were
incubated with 500 nM bafilomycin A1 for 30 min and then infected with S. aureus at an MOI of 2 for 85 min. The total RNA was extracted and analyzed for
TNF-αmRNA by RT-PCR. (B) ELISA analysis of TNF-α released from the indicated cell lines treated with or without bafilomycin A1 (bafilo) and then infected
with S. aureus at an MOI of 4 for 120 min. (C) ELISA analysis of TNF-α released from the indicated Dox-treated or -untreated cell lines treated with or without
NLRP3 Mediates NF-κB Activation
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mutations [19]. The smaller amounts and slower kinetics of cytokines induced by MSU (Fig. 3)
compared with those induced by microbial infection (Fig. 1) may reflect the absence of TLR
signaling in response to MSU.
Genetic reconstitution experiments with HEK293 cells have demonstrated that ASC can
mediate NF-κB activation. ASC has also been reported to mediate NF-κB and MAPK activa-
tion following bacterial infection in THP-1 cells [25, 36]. However, one study concluded that
NLRP3 is not required to activate MAPKs [36]. Whether ASC mediates the NLRP3-induced
NF-κB activation under physiological conditions has not been clarified. Our knockdown ex-
periments indicated that both NLRP3 and ASC are essential for the S. aureus-induced activa-
tion of NF-κB but not MAPKs, indicating that ASC mediates the NLRP3-induced NF-κB
activation, but NLRP3 and ASC are not involved in MAPK activation under these conditions.
The different results in terms of the involvement of ASC in MAPK activation may be due to
different infectious agents between this and the previous study.
Our previous genetic reconstitution experiments using HEK293 cells demonstrated that cas-
pase-8 is involved in ASC-mediated NF-κB activation [28, 37]. However, neither caspase-8
knockdown nor pretreatment with a caspase-8 inhibitor affected the S. aureus-induced NF-κB
activation and cytokine gene expression in THP-1 cells (data not shown). Thus, at least one
more mechanism exists for ASC-mediated NF-κB activation under these conditions. In this
context, it should be note that NLRP3 and ASC have been reported to interact with MAVS and
RIPK2, respectively [38–40], that could connect the NLRP3-ASC axis to NF-κB activation
pathways. Further study is required to clarify how NLRP3 and ASC activated NF-κB in our
experimental conditions.
Although NLRP3 has been linked to inflammasome in many microbially and sterile inflam-
matory responses, inflammasome-independent role for NLRP3 has also been reported [41–43].
In our study, pre-treatment with YVAD had no effect on cytokine induction in THP-1 and pri-
mary human monocytes (Fig. 4C, Fig. 4F, and Fig. E in S1 File). These suggest a novel caspase-
1-independent pathway for NF-κB activation through NLRP3 in immune cells.
In summary, our results indicate that NLRP3 mediates the NF-κB activation in sterile in-
flammatory and microbially induced immune responses. So far, NLRP3 has been implicated in
procaspase-1 activation through inflammasome formation. Our findings significantly broaden
NLRP3's physiological importance in innate immunity: NLRP3 not only activates caspase-1
post-translationally, but also induces multiple cytokine genes, including IL1B.
Supporting Information
S1 File. Supporting figures. Fig. A, IL-8 secretion following S. aureus infection was dampened
in Dox-treated NLRP3- and ASC-knockdown cells. Fig. B, NLRP3 and ASC was dispensable
for TNF-α and IL-8 production at 180 min after S. aureus infection. Fig. C, Establishment of
shRNA-based knockdown cells, and evaluation of TNF-α and IL-1β induction following S. au-
reus infection. Fig. D, The involvement of NLRP3 and ASC in MSU-induced TNF-α and IL-1β
expression. Fig. E, Caspase-1 inhibitor Ac-YVAD-CMK did not inhibit aluminium adjuvant-
induced TNF-α and IL-1βmRNA expression in primary human monocytes.
(PDF)
CA-074Me (20 μM) for 30 min, and then infected with S. aureus at an MOI of 4 for 100 min. (D and E) ELISA analysis of TNF-α released from THP-1 cells
treated with or without cytochalasin D (0.25 μM), bafilomycin A1 (0.5 μM), or DPI (2 μM), and then stimulated with MSU for 3 h. All results are representative
of three independent experiments. **P<0.01.
doi:10.1371/journal.pone.0119179.g005
NLRP3 Mediates NF-κB Activation
PLOS ONE | DOI:10.1371/journal.pone.0119179 March 11, 2015 12 / 15
Author Contributions
Conceived and designed the experiments: TK TS. Performed the experiments: TK. Analyzed
the data: TK. Contributed reagents/materials/analysis tools: TK RI HK TS. Wrote the paper:
TK TS.
References
1. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, et al. The NLRP3 inflamma-
some mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity.
2009; 30:556–565. doi: 10.1016/j.immuni.2009.02.005 PMID: 19362020
2. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, et al. Neisseria gonor-
rhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-
containing inflammasome. J Immunol. 2009; 182:6460–6469. doi: 10.4049/jimmunol.0802696 PMID:
19414800
3. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, et al. Syk kinase signalling
couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 2009; 459:433–436. doi: 10.
1038/nature07965 PMID: 19339971
4. Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, Nunez G. Activation of the Nlrp3 inflamma-
some by Streptococcus pyogenes requires streptolysin O and NF-kappaB activation but proceeds inde-
pendently of TLR signaling and P2X7 receptor. J Immunol. 2009; 183:5823–5829. doi: 10.4049/
jimmunol.0900444 PMID: 19812205
5. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, et al. NOD2 contributes to cutane-
ous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation.
Proc Natl Acad Sci U S A. 2009; 106:12873–12878. doi: 10.1073/pnas.0904958106 PMID: 19541630
6. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, et al. The intracellular sensor
NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1.
Immunity. 2009; 30:566–575. doi: 10.1016/j.immuni.2009.02.006 PMID: 19362023
7. Toma C, Higa N, Koizumi Y, Nakasone N, Ogura Y, McCoy AJ, et al. Pathogenic Vibrio activate NLRP3
inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa
B signaling. J immunol. 2010; 184:5287–5297. doi: 10.4049/jimmunol.0903536 PMID: 20348425
8. Cassel SL, Sutterwala FS. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur
J Immunol. 2010; 40:607–611. doi: 10.1002/eji.200940207 PMID: 20201012
9. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;
10:826–837. doi: 10.1038/nri2873 PMID: 21088683
10. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes
are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464:1357–1361.
doi: 10.1038/nature08938 PMID: 20428172
11. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflamma-
some is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008; 9:857–865. doi:
10.1038/ni.1636 PMID: 18604209
12. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small
antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006; 440:233–236. PMID:
16407888
13. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin acti-
vates the inflammasome in response to toxins and ATP. Nature. 2006; 440:228–232. PMID: 16407890
14. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 2006; 440:237–241. PMID: 16407889
15. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT, et al. Cholesterol crystals
activate the NLRP3 inflammasome in humanmacrophages: a novel link between cholesterol metabo-
lism and inflammation. PLoS One. 2010; 5:e11765. doi: 10.1371/journal.pone.0011765 PMID:
20668705
16. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation
through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008; 320:674–677. doi: 10.
1126/science.1156995 PMID: 18403674
17. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum
salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;
9:847–856. doi: 10.1038/ni.1631 PMID: 18604214
NLRP3 Mediates NF-κB Activation
PLOS ONE | DOI:10.1371/journal.pone.0119179 March 11, 2015 13 / 15
18. Hoffman HM, Brydges SD. The genetic and molecular basis of inflammasome-mediated disease. J Biol
Chem. 2011; 286:10889–10896. doi: 10.1074/jbc.R110.135491 PMID: 21296874
19. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-
processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immuni-
ty. 2004; 20:319–325. PMID: 15030775
20. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G. Inflammasomes as microbial sensors.
Eur J Immunol. 2010; 40:611–615. doi: 10.1002/eji.200940180 PMID: 20201013
21. Latz E. The inflammasomes: mechanisms of activation and function. Curr. 2010; 22:28–33.
22. Schroder K, Tschopp J. The inflammasomes. Cell. 2010; 140:821–832. doi: 10.1016/j.cell.2010.01.040
PMID: 20303873
23. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. PYPAF3, a PYRIN-containing APAF-1-like
protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem.
2005; 280:21720–21725. PMID: 15817483
24. Manji GA, Wang L, Geddes BJ, BrownM, Merriam S, Al-Garawi A, et al. PYPAF1, a PYRIN-containing
Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem.
2002; 277:11570–11575. PMID: 11786556
25. Taxman DJ, Zhang J, Champagne C, Bergstralh DT, Iocca HA, Lich JD, et al. Cutting edge: ASCmedi-
ates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -in-
dependent pathways. J Immunol. 2006; 177:4252–4256. PMID: 16982856
26. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear
cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
Scand J Clin Lab Invest Suppl. 1968; 97:77–89. PMID: 4179068
27. Motani K, Kawase K, Imamura R, Kinoshita T, Kushiyama H, Suda T. Activation of ASC induces apo-
ptosis or necrosis, depending on the cell type, and causes tumor eradication. Cancer Sci. 2010;
101:1822–1827. doi: 10.1111/j.1349-7006.2010.01610.x PMID: 20500518
28. Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, et al. Fas ligand induces cell-
autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of
tumor necrosis factor-alpha. J Biol Chem. 2004; 279:46415–46423. PMID: 15337758
29. Tschopp J, Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling path-
ways on ROS production? Nat Rev Immunol. 2010; 10:210–215. doi: 10.1038/nri2725 PMID:
20168318
30. Hornung V, Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J
Immunol. 2010; 40:620–623. doi: 10.1002/eji.200940185 PMID: 20201015
31. Willingham SB, Bergstralh DT, O'Connor W, Morrison AC, Taxman DJ, Duncan JA, et al. Microbial
pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/
NLRP3 and ASC. Cell Host Microbe. 2007; 2:147–159. PMID: 18005730
32. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, et al. The matrix component
biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin In-
vest. 2005; 115:2223–2233. PMID: 16025156
33. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like re-
ceptors and hyaluronan. Nat Med. 2005; 11:1173–1179. PMID: 16244651
34. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, et al. Biglycan,
a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem.
2009; 284:24035–24048. doi: 10.1074/jbc.M109.014266 PMID: 19605353
35. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, et al. NLRP3/cryopyrin is necessary for
interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation
in response to injury. J Biol Chem. 2009; 284:12762–12771. doi: 10.1074/jbc.M806084200 PMID:
19258328
36. Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, Allen IC, et al. The NLR adaptor
ASC/pycard regulates DUSP10, MAP kinase (MAPK) and chemokine induction independent of the
inflammasome. J Biol Chem. 2011; 286:19605–19616. doi: 10.1074/jbc.M111.221077 PMID:
21487011
37. Hasegawa M, Imamura R, Kinoshita T, Matsumoto N, Masumoto J, Inohara N, et al. ASC-mediated
NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by
CLARP. J Biol Chem. 2005; 280:15122–15130. PMID: 15701651
38. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. The Adaptor MAVS Promotes
NLRP3 Mitochondrial Localization and Inflammasome Activation. Cell. 2013; 153:348–361. doi: 10.
1016/j.cell.2013.02.054 PMID: 23582325
NLRP3 Mediates NF-κB Activation
PLOS ONE | DOI:10.1371/journal.pone.0119179 March 11, 2015 14 / 15
39. Taxman DJ, Lei Y, Zhang S, Holley-Guthrie E, Offenbacher S, Ting JP. ASC-dependent RIP2 kinase
regulates reduced PGE2 production in chronic periodontitis. J Dent Res. 2012; 91:877–882. doi: 10.
1177/0022034512454541 PMID: 22828789
40. Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, et al. The mitochondrial antiviral
protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 2013;
191:4358–4366. doi: 10.4049/jimmunol.1301170 PMID: 24048902
41. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, et al. An inflammasome-indepen-
dent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 2010;
185:6277–6285. doi: 10.4049/jimmunol.1002330 PMID: 20962258
42. WangW,Wang X, Chun J, Vilaysane A, Clark S, French G, et al. Inflammasome-Independent NLRP3
Augments TGF-beta Signaling in Kidney Epithelium. J Immunol. 2012; 190:1239–1249. doi: 10.4049/
jimmunol.1201959 PMID: 23264657
43. Zuurbier CJ, JongWM, Eerbeek O, Koeman A, PulskensWP, Butter LM, et al. Deletion of the innate im-
mune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-
6/STAT3 signaling. PLoS One. 2012; 7:e40643. doi: 10.1371/journal.pone.0040643 PMID: 22848390
NLRP3 Mediates NF-κB Activation
PLOS ONE | DOI:10.1371/journal.pone.0119179 March 11, 2015 15 / 15
